Endogenous mammalian RF-amide peptides, including PrRP, kisspeptin and 26RFa, modulate nociception and morphine analgesia via NPFF receptors.

Abstract

Mammalian RF-amide peptides are encoded by five different genes and act through five different G protein-coupled receptors. RF-amide-related peptides-1 and -3, neuropeptides AF and FF, Prolactin releasing peptides, Kisspeptins and RFa peptides are currently considered endogenous peptides for NPFF1, NPFF2, GPR10, GPR54 and GPR103 receptors, respectively. However, several studies suggest that the selectivity of these peptides for their receptors is low and indicate that expression patterns for receptors and their corresponding ligands only partially overlap. In this study, we took advantage of the cloning of the five human RF-amide receptors to systematically examine their affinity for and their activation by all human RF-amide peptides. Binding experiments, performed on membranes from CHO cells expressing GPR10, GPR54 and GPR103 receptors, confirmed their high affinity and remarkable selectivity for their cognate ligands. Conversely, NPFF1 and NPFF2 receptors displayed high affinity for all RF-amide peptides. Moreover, GTPγS and cAMP experiments showed that almost all RF-amide peptides efficiently activate NPFF1 and NPFF2 receptors. As NPFF is known to modulate morphine analgesia, we undertook a systematic analysis in mice of the hyperalgesic and anti morphine-induced analgesic effects of a representative set of endogenous RF-amide peptides. All of them induced hyperalgesia and/or prevented morphine analgesia following intracerebroventricular administration. Importantly, these effects were prevented by administration of RF9, a highly selective NPFF1/NPFF2 antagonist. Altogether, our results show that all endogenous RF-amide peptides display pain-modulating properties and point to NPFF receptors as essential players for these effects.

• Authors: Khadija Elhabazi, Jean-Paul Humbert, Isabelle Bertin, Martine Schmitt, Frédéric Bihel, Jean-Jacques Bourguignon, Bernard Bucher, Jérôme A J Becker, Tania Sorg, Hamid Meziane, Benoit Petit-Demoulière, Brigitte Ilien, Frédéric Simonin
• Journal: Neuropharmacology (Neuropharmacology) Vol. 75 Pg. 164-71 (Dec 2013) ISSN: 1873-7064 [Electronic] England
• PMID: 23911743 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2013 Elsevier Ltd. All rights reserved.

Chemical References

• Analgesics, Opioid
• KISS1 protein, human
• Kisspeptins
• Neuropeptides
• PRLH protein, human
• Prolactin-Releasing Hormone
• Receptors, Neuropeptide
• neuropeptide FF receptor
• prepro-26RFa protein, human
• Tritium
• Guanosine 5'-O-(3-Thiotriphosphate)
• Morphine
• Cyclic AMP
• Calcium

Topics

• Analgesics, Opioid (pharmacology)
• Animals
• CHO Cells
• Calcium (metabolism)
• Cricetulus
• Cyclic AMP (metabolism)
• Guanosine 5'-O-(3-Thiotriphosphate) (pharmacokinetics)
• Humans
• Kisspeptins (genetics, metabolism)
• Male
• Mice
• Mice, Inbred C57BL
• Morphine (pharmacology)
• Neuropeptides (genetics, metabolism)
• Pain Threshold (drug effects)
• Prolactin-Releasing Hormone (genetics, metabolism)
• Protein Binding (drug effects)
• Receptors, Neuropeptide (metabolism)
• Time Factors
• Tritium (pharmacokinetics)